Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DNK333 for COPD and Cough
NCT01287325Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2003
- Primary completion
- Apr 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of DNK333 in chronic obstructive pulmonary disease (COPD), cough, sponsored by Novartis. Started Sep 2003; status: completed.
02
Drugs
DNK333
03
Conditions
chronic obstructive pulmonary disease (COPD)cough
Beyond the preview
Go deeper on NCT01287325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01287325.